Overexpression of the HER2/neu oncogene has been found in approximately 30% of all invasive BCs and correlates with more unfettered and destructive tumor growth and greater resistance to cancer chemotherapy [3,4,5]. This evidence concerns the gene ERBB2 and neoplasm.